v1
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).
- NobleID
- NI5P50W40R16S57
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/F7752CB4
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →